The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 6: 756 - 761

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.06.005

Feature Reports：Hepatocellular Carcinoma

Study on the mechanism of fatty acid binding protein 5 binding Vimentin protein in the Hepatocellular Carcinoma cells

  • Yanping TANG ,
  • Kezhi LI ,
  • Zhengmin CAI ,
  • Hao TAO ,
  • Jiaying TANG ,
  • Xueyu LI ,
  • Yanjuan LI ,
  • Ji CAO
Expand
  • Research Department，Guangxi Medical University Cancer Hospital，Nanning 530021，China

Received date: 2023-11-20

  Online published: 2024-04-08

Fold

Abstract

Objective The aim of this study was to screen and verify the proteins interacting with Vimentin， investigate the regulatory relationship between FABP5 and candidate proteins， and further explore the mechanism of FABP5 in hepatocellular carcinoma. Methods Immunoprecipitation combined with tandem mass spectrometry （IP?MS） was used to screen the proteins that bind to FABP5. The binding relationship between FABP5 and candidate interacting proteins was verified from the exogenous and endogenous levels by Co?immune precipitation assay （Co?IP）. RT?qPCR， Western blot and immunofluorescence were used to observe the effect of knockdown FABP5 on the transcription and translation of Vimentin in HCC cells. The effect of overexpressing FABP5 on the cytoskeleton of HCC cell was observed by phalloidin staining. Results 336 potential target proteins that bind to FABP5 were identified through IP?MS. Based on literature， five candidate proteins related to tumors were selected， namely PRDX1， PRSS3， PKM， HSP90AA1， and Vimentin. The binding relationship between FABP5 and Vimentin protein was confirmed through both exogenous and endogenous Co?IP. Knockdown FABP5 has no significant effect on the expression of Vimentin mRNA， but it can inhibit the expression of Vimentin protein， and overexpression of FABP5 can affect the cytoskeleton of HCC cell. Conclusions FABP5 promotes the migration and invasion of HCC cells by the regulation of Vimentin and the influence of cytoskeletal remodeling， and thus it is expected to be a potential target for anti?HCC and provide new ideas for the treatment of HCC.

Key words： fatty acid binding protein 5; Vimentin; liver cancer; mass spectrometry; interacting protein

Cite this article

Yanping TANG , Kezhi LI , Zhengmin CAI , Hao TAO , Jiaying TANG , Xueyu LI , Yanjuan LI , Ji CAO . Study on the mechanism of fatty acid binding protein 5 binding Vimentin protein in the Hepatocellular Carcinoma cells[J]. The Journal of Practical Medicine, 2024 , 40(6) : 756 -761 . DOI: 10.3969/j.issn.1006-5725.2024.06.005

References

1 张思维， 郑荣寿， 孙可欣， 等. 2016年中国恶性肿瘤分地区发病和死亡估计：基于人群的肿瘤登记数据分析［J］. 中国肿瘤， 2023， 32（5）： 321-332. doi:10.11735/j.issn.1004-0242.2023.05.A001
2 NITSCHKE K， ERBEN P， WALDBILLIG F， et al. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5［J］. World J Urol， 2020， 38（3）： 637-645. doi:10.1007/s00345-019-02651-8
3 APAYA M K， HSIAO P W， YANG Y C， et al. Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer［J］. Cancers， 2020， 12（1）： 199. doi:10.3390/cancers12010199
4 GARCIA K A， COSTA M L， LACUNZA E， et al. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma［J］. Life Sci， 2022， 301： 120621. doi:10.1016/j.lfs.2022.120621
5 WANG W， LIU Z， CHEN X， et al. FABP5 Downregulation of Suppresses the Proliferation and Induces the Apoptosis of Gastric Cancer Cells Through the Hippo Signaling Pathway［J］. DNA Cell Biol， 2021， 40（8）： 1076-1086. doi:10.1089/dna.2021.0370
6 史俊林， 曹骥， 苏建家， 等. 表皮型脂肪酸结合蛋白在不同种属肝癌组织中的高表达及其临床意义［J］. 世界华人消化杂志， 2013， 21（11）： 963-969.
7 周玲丽， 曹骥， 李薇， 等. 沉默FABP-5基因对人肝癌HepG2细胞的影响［J］. 世界华人消化杂志， 2015， 23（2）： 179-188.
8 LI B， HAO J， ZENG J， et al. SnapShot： FABP Functions［J］. Cell， 2020， 182（4）： 1066-1066.e1061. doi:10.1016/j.cell.2020.07.027
9 WANG J， ZHAO S， SUN J， et al. Oncogenic role and potential regulatory mechanism of fatty acid binding protein 5 based on a pan-cancer analysis［J］. Sci Rep，2023， 13（1）： 4060. doi:10.1038/s41598-023-30695-9
10 TANG Y， LI K， HU B， et al. Fatty acid binding protein 5 promotes the proliferation， migration， and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein［J］. Cancer Biol Ther， 2022， 23（1）： 424-438. doi:10.1080/15384047.2022.2094670
11 吴新华， 顾晓荔， 胡滨. MiR-216a调节JAK2/STAT3通路抑制卵巢癌细胞的转移和上皮-间质转化［J］. 实用医学杂志， 2022， 38（18）： 2303-2308.
12 WANG Y， WAHAFU A， WU W， et al. FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling［J］. J Cell Mol Med， 2021， 25（9）： 4487-4500. doi:10.1111/jcmm.16536
13 LU F， YE M， HU C， et al. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway［J］. Cancer Sci， 2023， 114（9）： 3553-3567. doi:10.1111/cas.15883
14 RIDGE K M， ERIKSSON J E， PEKNY M， et al. Roles of vimentin in health and disease［J］. Genes Dev， 2022， 36（7-8）： 391-407. doi:10.1101/gad.349358.122
15 CHANG W H， CHEN Y J， HSIAO Y J， et al. Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP-deficient lung cancer［J］. EMBO Rep， 2022， 23（8）： e54265. doi:10.15252/embr.202154265
16 YOU H， YUAN D， BI Y， et al. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis［J］. Cell Commun Signal， 2021， 19（1）： 33. doi:10.1186/s12964-021-00714-1
17 李梦妍， 侯国胜， 高永梅，等. CRABP2、FABP5、RARγ和PPARβ/δ在食管鳞癌中的表达及临床意义［J］. 现代肿瘤医学， 2023， 31（8）： 1448-1455.
18 HUANG X， XIANG L， WANG B， et al. CMTM6 promotes migration， invasion， and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells［J］. J Transl Med， 2021， 19（1）： 120. doi:10.1186/s12967-021-02787-5
19 LIU S， HUANG J， ZHANG Y， et al. MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis［J］. Aging， 2019， 11（22）： 10697-10710. doi:10.18632/aging.102485
20 PAULIN D， LILIENBAUM A， KARDJIAN S， et al. Vimentin： Regulation and pathogenesis［J］. Biochimie， 2022， 197： 96-112. doi:10.1016/j.biochi.2022.02.003
21 HU W M， LI M， NING J Z， et al. FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression［J］. J Exp Clin Cancer Res， 2023， 42（1）： 290. doi:10.1186/s13046-023-02860-5
22 FAN C， SHI X， ZHAO K， et al. Cell migration orchestrates migrasome formation by shaping retraction fibers［J］. J Cell Biol， 2022， 221（4）： e202109168. doi:10.1083/jcb.202109168
23 LU Y， HUANG D， WANG B， et al. FAM21C Promotes Hepatocellular Carcinoma Invasion and Metastasis by Driving Actin Cytoskeleton Remodeling via Inhibiting Capping Ability of CAPZA1［J］. Front Oncol， 2021， 11： 809195. doi:10.3389/fonc.2021.809195
24 HUANG Y， HONG W， WEI X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis［J］. J Hematol Oncol， 2022， 15（1）： 129. doi:10.1186/s13045-022-01347-8
25 KAROII D H， AZIZI H， AMIRIAN M. Signaling Pathways and Protein-Protein Interaction of Vimentin in Invasive and Migration Cells： A Review［J］. Cell reprogram， 2022， 24（4）： 165-174. doi:10.1089/cell.2022.0025
Options
Outlines

/

〈 〉